mesalamine has been researched along with Retinal Degeneration in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, X | 1 |
| Yu, G | 1 |
| Luo, C | 1 |
| Maeda, A | 1 |
| Zhang, N | 1 |
| Sun, D | 1 |
| Zhou, Z | 1 |
| Puntel, A | 1 |
| Palczewski, K | 1 |
| Lu, ZR | 1 |
1 other study available for mesalamine and Retinal Degeneration
| Article | Year |
|---|---|
Synthesis and evaluation of a nanoglobular dendrimer 5-aminosalicylic Acid conjugate with a hydrolyzable schiff base spacer for treating retinal degeneration.
Topics: Dendrimers; Humans; Hydrolysis; Mesalamine; Nanostructures; Retinal Degeneration; Schiff Bases | 2014 |